Dr. Richard Pazdur is “likely the best possible person for the role,” says one analyst. A calmer course for the FDA could add ...

In a highly anticipated article, FDA officials Vinay Prasad, M.D., and Martin Makary, M.D., outlined a novel regulatory ...

QUT researchers have recovered the genomes of more than 24,000 previously unknown microbial species—some from entirely new ...

Investors have once again turned to Chinese pharmaceutical company Jiangsu Hengrui to create a new biotech startup, this time ...

China’s biotech renaissance is gathering pace as home-grown innovators strike billion-dollar licensing deals with global ...

California biotech company Cellipont has opened a new 76,000 square foot cell therapy headquarters in The Woodlands' booming ...

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...

New Wave Biotech has launched a new Life Cycle Assessment (LCA) tool tailored to the biotechnology sector, designed to provide real-time visibility into the ...

A US politician just disclosed the purchase of multiple new stocks, including two in biotechnology and research – a sector ...

The L’Oréal-owned legacy brand’s new strategic vision, High-Tech Nature, combines nature with cutting-edge green technology ...

A dropoff in venture capital investments has driven that slowdown. City biotech companies raised nearly $531 million from ...